REPR - Repro Med Systems, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

Repro Med Systems, Inc.

24 Carpenter Road
Chester, NY 10918
United States
845-469-2042
http://www.rmsmedicalproducts.com

SectorHealthcare
IndustryMedical Instruments & Supplies
Full Time Employees75

Key Executives

NameTitlePayExercisedYear Born
Mr. Daniel S. GoldbergerExec. Chairman158.61kN/A1959
Mr. Donald B. PettigrewCEO, Pres & Chief Commercial Officer160.21kN/A1968
Ms. Karen FisherCFO, Treasurer & Corp. Sec.273kN/A1966
Mr. Manuel A. MarquesChief Operating OfficerN/AN/A1973
Mr. Craig S. RossVP of Sales & MarketingN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Repro Med Systems, Inc., doing business as RMS Medical Products, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and RMS precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems, Inc. was founded in 1980 and is headquartered in Chester, New York.

Corporate Governance

Repro Med Systems, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.